Morris, David L.

In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole

Pourgholami, M. H., Woon, L., Almajd, R., Akhter, J., Bowery, P., & Morris, D. L. (2001) · Cancer Letters

Heterocyclic Compound Synthesis and BioactivityMicrotubule and mitosis dynamics

Cited by 139

Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer

Pourgholami, M. H., Szwajcer, M., Chin, M., Liauw, W., Seef, J., Galettis, P., Morris, D. L., & Links, M. (2010) · Cancer Chemotherapy and Pharmacology

Cancer therapeutics and mechanismsCancer Treatment and Pharmacology

Cited by 69

Pilot Study of Albendazole in Patients with Advanced Malignancy

Morris, D. L., Jourdan, J.-L., & Pourgholami, M. H. (2001) · Oncology

Colorectal Cancer Treatments and StudiesCancer therapeutics and mechanisms

Cited by 66

Albendazole in hydatid disease—hepatocellular toxicity

Morris, D. L., & Smith, P. G. (1987) · Transactions of the Royal Society of Tropical Medicine and Hygiene

Parasitic infections in humans and animalsDrug-Induced Hepatotoxicity and Protection

Cited by 54

Combination of Albendazole and 2-Methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice

Ehteda, A., Galettis, P., Pillai, K., & Morris, D. L. (2013) · BMC Cancer

Microtubule and mitosis dynamicsCancer Treatment and Pharmacology

Cited by 44